Carbon-11 Butanol: Whole Body Radiochemical and Radiation Safety

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 17, 2020

Primary Completion Date

December 29, 2020

Study Completion Date

January 5, 2021

Conditions

Neuro-Degenerative Disease

Interventions

DRUG

Carbon 11 Butanol

Two sequential administrations of a PET tracer

Trial Locations (1)

Weill Cornell Medicine, New York

All Listed Sponsors

lead

Weill Medical College of Cornell University

OTHER

NCT04050800 - Carbon-11 Butanol: Whole Body Radiochemical and Radiation Safety | Biotech Hunter | Biotech Hunter